2,4,6-Tribromo-m-cresol

    WARNING: This product is for research use only, not for human or veterinary use.

MedKoo CAT#: 532492

CAS#: 4619-74-3

Description: 2,4,6-Tribromo-m-cresol is a bioactive chemical.

Chemical Structure

img
2,4,6-Tribromo-m-cresol
CAS# 4619-74-3
Instruction

Theoretical Analysis

MedKoo Cat#: 532492
Name: 2,4,6-Tribromo-m-cresol
CAS#: 4619-74-3
Chemical Formula: C7H5Br3O
Exact Mass: 341.79
Molecular Weight: 344.828
Elemental Analysis: C, 24.38; H, 1.46; Br, 69.52; O, 4.64

Price and Availability

This product is not in stock, which may be available by custom synthesis. For cost-effective reason, minimum order is 1g (price is usually high, lead time is 2~3 months, depending on the technical challenge). Quote less than 1g will not be provided. To request quote, please email to sales @medkoo.com or click below button.
Note: Price will be listed if it is available in the future.

Request quote for custom synthesis

Synonym: 2,4,6-Tribromo-m-cresol

IUPAC/Chemical Name: 2,4,6-Tribromo-m-cresol

InChi Key: QKHROXOPRBWBDD-UHFFFAOYSA-N

InChi Code: InChI=1S/C7H5Br3O/c1-3-4(8)2-5(9)7(11)6(3)10/h2,11H,1H3

SMILES Code: CC1=C(Br)C(O)=C(Br)C=C1Br

Appearance: Solid powder

Purity: >98% (or refer to the Certificate of Analysis)

Shipping Condition: Shipped under ambient temperature as non-hazardous chemical. This product is stable enough for a few weeks during ordinary shipping and time spent in Customs.

Storage Condition: Dry, dark and at 0 - 4 C for short term (days to weeks) or -20 C for long term (months to years).

Solubility: Soluble in DMSO

Shelf Life: >3 years if stored properly

Drug Formulation: This drug may be formulated in DMSO

Stock Solution Storage: 0 - 4 C for short term (days to weeks), or -20 C for long term (months).

HS Tariff Code: 2934.99.9001

More Info:

Biological target:
In vitro activity:
In vivo activity:

Preparing Stock Solutions

The following data is based on the product molecular weight 344.83 Batch specific molecular weights may vary from batch to batch due to the degree of hydration, which will affect the solvent volumes required to prepare stock solutions.

Recalculate based on batch purity %
Concentration / Solvent Volume / Mass 1 mg 5 mg 10 mg
1 mM 1.15 mL 5.76 mL 11.51 mL
5 mM 0.23 mL 1.15 mL 2.3 mL
10 mM 0.12 mL 0.58 mL 1.15 mL
50 mM 0.02 mL 0.12 mL 0.23 mL
Formulation protocol:
In vitro protocol:
In vivo protocol:

Molarity Calculator

Calculate the mass, volume, or concentration required for a solution.
=
x
x
g/mol

*When preparing stock solutions always use the batch-specific molecular weight of the product found on the vial label and SDS / CoA (available online).

Reconstitution Calculator

The reconstitution calculator allows you to quickly calculate the volume of a reagent to reconstitute your vial. Simply enter the mass of reagent and the target concentration and the calculator will determine the rest.

=
÷

Dilution Calculator

Calculate the dilution required to prepare a stock solution.
x
=
x

1: Hwang BH, Jung KA, Ong A, Ahn HS, Moon SH, Lee SC. Patellar Impingement on
Tibial Polyethylene after Primary Total Knee Arthroplasty without Patellar
Resurfacing. J Knee Surg. 2019 Aug 30. doi: 10.1055/s-0039-1695704. [Epub ahead
of print] PubMed PMID: 31470453.


2: Deren ME, Pannu TS, Villa JM, Firtha M, Riesgo AM, Higuera CA. Meta-analysis
Comparing Allograft to Synthetic Reconstruction for Extensor Mechanism Disruption
after Total Knee Arthroplasty. J Knee Surg. 2019 Aug 30. doi:
10.1055/s-0039-1696656. [Epub ahead of print] PubMed PMID: 31470450.


3: Fanikos J, Murwin D, Gruenenfelder F, Tartakovsky I, França LR, Reilly PA,
Kermer P, Wowern FV, Lane DA, Butcher K. Global Use of Idarucizumab in Clinical
Practice: Outcomes of the RE-VECTO Surveillance Program. Thromb Haemost. 2019 Aug
30. doi: 10.1055/s-0039-1695771. [Epub ahead of print] PubMed PMID: 31470445.


4: Franchi F, Rollini F, Garcia E, Rivas Rios J, Rivas A, Agarwal M, Kureti M,
Nagaraju D, Wali M, Briceno M, Moon JY, Kairouz V, Yaranov D, Been L, Suryadevara
S, Soffer D, Zenni MM, Bass TA, Angiolillo DJ. Effects of Edoxaban on the
Cellular and Protein Phase of Coagulation in Patients with Coronary Artery
Disease on Dual Antiplatelet Therapy with Aspirin and Clopidogrel: Results of the
EDOX-APT Study. Thromb Haemost. 2019 Aug 30. doi: 10.1055/s-0039-1695772. [Epub
ahead of print] PubMed PMID: 31470444.


5: McCarthy J, Comerford EJ, Innes JF, Pettitt RA. Elbow Arthrodesis Using a
Medially Positioned Plate in 6 Dogs. Vet Comp Orthop Traumatol. 2019 Aug 30. doi:
10.1055/s-0039-1694783. [Epub ahead of print] PubMed PMID: 31470442.


6: Dodson T, Halliburton LE, Kedziora G, Lenyk C, Giles N. Self-trapped holes
(small polarons) in ferroelectric KH2PO4 crystals. J Phys
Condens Matter. 2019 Aug 30. doi: 10.1088/1361-648X/ab3fe9. [Epub ahead of print]
PubMed PMID: 31470431.


7: Rong S, Zhang P, Liu F. Scalable synthesis of water-dispersible
two-dimensional manganese dioxide monosheets. J Phys Condens Matter. 2019 Aug 30.
doi: 10.1088/1361-648X/ab401d. [Epub ahead of print] PubMed PMID: 31470427.


8: Harmon KK, Girts RM, MacLennan RJ, Stock MS. Is the motor unit mean firing
rate versus recruitment threshold relationship linear? Physiol Meas. 2019 Aug 30.
doi: 10.1088/1361-6579/ab4025. [Epub ahead of print] PubMed PMID: 31470424.


9: Van de Velde F, Bekaert M, Geerts A, Hoorens A, Batens AH, Samyah S, Ouwens M,
Van Nieuwenhove Y, Lapauw B. Insulin resistance associates with hepatic lobular
inflammation in subjects with obesity. Endocr Connect. 2019 Aug 1. pii:
EC-19-0366.R1. doi: 10.1530/EC-19-0366. [Epub ahead of print] PubMed PMID:
31470414.


10: Rutland JW, Huang KH, Gill CM, Villavisanis DF, Alper J, Verma G, Bederson
JB, Delman BN, Shrivastava RK, Balchandani P. First application of 7-T ultra-high
field diffusion tensor imaging to detect altered microstructure of
thalamic-somatosensory anatomy in trigeminal neuralgia. J Neurosurg. 2019 Aug
30:1-9. doi: 10.3171/2019.6.JNS19541. [Epub ahead of print] PubMed PMID:
31470412.


11: Häni L, Vulcu S, Branca M, Fung C, Z'Graggen WJ, Murek M, Raabe A, Beck J,
Schucht P. Subdural versus subgaleal drainage for chronic subdural hematomas: a
post hoc analysis of the TOSCAN trial. J Neurosurg. 2019 Aug 30:1-9. doi:
10.3171/2019.5.JNS19858. [Epub ahead of print] PubMed PMID: 31470410.


12: Hung YC, Mohammed N, Eluvathingal Muttikkal TJ, Kearns KN, Li CE, Narayan A,
Schlesinger D, Xu Z, Sheehan JP. The impact of preradiosurgery embolization on
intracranial arteriovenous malformations: a matched cohort analysis based on de
novo lesion volume. J Neurosurg. 2019 Aug 30:1-12. doi: 10.3171/2019.5.JNS19722.
[Epub ahead of print] PubMed PMID: 31470409.


13: Wang CH, Qi ST, Fan J, Pan J, Peng JX, Nie J, Bao Y, Liu YW, Zhang X, Liu Y.
Identification of tumor stem-like cells in admanatimomatous craniopharyngioma and
determination of these cells' pathological significance. J Neurosurg. 2019 Aug
30:1-11. doi: 10.3171/2019.5.JNS19565. [Epub ahead of print] PubMed PMID:
31470408.


14: Butenschoen VM, Seifert M, Meyer B, Krieg SM. Presence of Propionibacterium
acnes in patients with aseptic bone graft resorption after cranioplasty:
preliminary evidence for low-grade infection. J Neurosurg. 2019 Aug 30:1-6. doi:
10.3171/2019.5.JNS191200. [Epub ahead of print] PubMed PMID: 31470407.


15: Jahangiri A, Flanigan PM, Arnush M, Chandra A, Rick JW, Choi S, Chou A,
Berger MS, Aghi MK. From bench to bedside: trends in National Institutes of
Health funding for neurosurgeons from 1991 to 2015. J Neurosurg. 2019 Aug
30:1-10. doi: 10.3171/2019.1.JNS181531. [Epub ahead of print] PubMed PMID:
31470404.


16: McAvoy M, McCrea HJ, Chavakula V, Choi H, Bi WL, Mekary RA, Stone S, Proctor
MR. Long-term outcomes of lumbar microdiscectomy in the pediatric population: a
large single-institution case series. J Neurosurg Pediatr. 2019 Aug 30:1-9. doi:
10.3171/2019.6.PEDS18716. [Epub ahead of print] PubMed PMID: 31470400.


17: Northam W, Chandran A, Quinsey C, Abumoussa A, Flores A, Elton S. Pediatric
nonoperative skull fractures: delayed complications and factors associated with
clinic and imaging utilization. J Neurosurg Pediatr. 2019 Aug 30:1-9. doi:
10.3171/2019.5.PEDS18739. [Epub ahead of print] PubMed PMID: 31470399.


18: Cheikh A, Bouatia M, Ajaja MR, El Malhouf N, Cherrah Y, Abouqal R, El Hassani
A. Impact of Disparities in Reimbursement Rules Between Public and Private
Sectors on Accessibility to Care in Moroccan Mandatory Health Insurance: A
Cross-Sectional Study. Value Health Reg Issues. 2019 Aug 26;19:132-137. doi:
10.1016/j.vhri.2019.07.008. [Epub ahead of print] PubMed PMID: 31470367.


19: Andritsos LA, Huang Y, Abraham I, Huff K, Scrape SR, Fan T, Alkhatib N,
Hofmeister CC, Drea E, McBride A. Clinical and cost outcomes of pre-emptive
plerixafor administration in patients with multiple myeloma undergoing stem cell
mobilization. Leuk Res. 2019 Aug 9;85:106215. doi: 10.1016/j.leukres.2019.106215.
[Epub ahead of print] PubMed PMID: 31470355.


20: Yang F, Zhang K, Li W, Xu K. Structure-designed synthesis of hierarchical
NiCo(2)O(4)@NiO composites for high-performance supercapacitors. J Colloid
Interface Sci. 2019 Aug 22;556:386-391. doi: 10.1016/j.jcis.2019.08.078. [Epub
ahead of print] PubMed PMID: 31470353.